| Financial Year |
March 31 2023 |
| Monetary Funds |
1,285,736,529.07 |
| Held-for-trading Financial Assets |
120,514,772.60 |
| Notes Receivable |
678,100,325.96 |
| Accounts Receivable |
503,074,840.37 |
| Advances to Suppliers |
24,005,632.57 |
| Other Receivables |
5,222,353.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
857,695,860.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,405,405.25 |
| Total Current Assets |
3,585,990,608.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,578,598.48 |
| Investment Properties |
3,597,897.55 |
| Fixed Assetes |
2,024,445,512.79 |
| Under-construction Projects |
446,617,685.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,305,894.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,167,291.46 |
| Deferred Income Tax Assets |
27,530,580.97 |
| Other Non-Current Assets |
18,919,916.33 |
| Sub-Total of Non-Current Assets |
2,708,483,772.65 |
| Total Assets |
6,294,474,381.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
730,975,967.07 |
| Accounts Payable |
731,805,272.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,595,683.01 |
| Taxes Payable |
23,525,765.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
170,926,220.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,537,621.20 |
| Other Current Liabilities |
1,911,086.00 |
| Sub-Total of Current Liabilities |
1,826,877,154.26 |
| Long-term Loans |
516,211,979.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
101,347,787.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
692,398,928.25 |
| Total Liabilities |
2,519,276,082.51 |
| Paid-In Capital(Or Share Stock) |
618,477,169.00 |
| Capital Surplus |
1,451,904,841.32 |
| Surplus Reserve |
304,379,643.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,400,391,931.21 |
| Minority Stockholder's Interest |
44,713.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,775,153,584.98 |
| Owner's Equity（Stockholder's Equity） |
3,775,198,298.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,294,474,381.23 |
